Precision Pathology Podcast (P³)

Precision Pathology Podcast (P³)

Perelman School of Medicine, Pathology & Laboratory Medicine

10 - How CAR T-Cell Therapy Enabled Kidney Transplants for Highly Sensitized Patients
Precision Pathology Podcast (P³) features monthly interviews hosted by George J. Netto, MD, Chair of Pathology and Laboratory Medicine at the University of Pennsylvania's Perelman School of Medicine. In each episode, he engages with global thought leaders and authors who are at the forefront of cutting- edge research in pathology and biomedical science. The discussions are easy to follow and highly informative, covering a wide range of groundbreaking technological advancements in precision diagnostics and therapeutics. Topics include digital and computational pathology, single-cell and spatial omics, as well as multiplex biomarker assessment, which are transforming diagnostics, targeted therapies, immunotherapy, and cellular therapeutics.
10 - How CAR T-Cell Therapy Enabled Kidney Transplants for Highly Sensitized Patients
00:00
00:00
Precision Pathology Podcast (P³) features monthly interviews hosted by George J. Netto, MD, Chair of Pathology and Laboratory Medicine at the University of Pennsylvania's Perelman School of Medicine. In each episode, he engages with global thought leaders and authors who are at the forefront of cutting- edge research in pathology and biomedical science. The discussions are easy to follow and highly informative, covering a wide range of groundbreaking technological advancements in precision diagnostics and therapeutics. Topics include digital and computational pathology, single-cell and spatial omics, as well as multiplex biomarker assessment, which are transforming diagnostics, targeted therapies, immunotherapy, and cellular therapeutics.

Episoder

10-

How CAR T-Cell Therapy Enabled Kidney Transplants for Highly Sensitized Patients

17 juli 2026
9-

Leveraging the Million Veteran Program Dataset to Bring a Prostate Genomic Risk to the Clinic: the ProGRESS study

16 juni 2026
8-

GLP-1 Receptor Agonists and Cancer Risk Reduction: What is the Verdict?

27 mai 2026
7-

Intercepting Pancreatic Cancer: KRAS Inhibitors in Action

28 apr. 2026
6-

Cutting Edge Technologies Unlocking Barrett's Esophagus Clonal Cell States

10 feb. 2026